linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Book Closure  
Astrazeneca Pharma India Ltd.
 
From Date To Date Purpose
03-Sep-18 10-Sep-18   A.G.M. 
06-Sep-17 13-Sep-17   A.G.M. 
04-Aug-16 11-Aug-16   A.G.M. 
24-Aug-15 02-Sep-15   A.G.M. 
22-Sep-14 30-Sep-14   A.G.M. 
11-Aug-13 20-Aug-13   A.G.M. 
11-Jul-12 18-Jul-12   Rs.3.50 per share(175%)Dividend & A.G.M. 
09-Jul-11 22-Jul-11  21/08/2011 Equity Rs.10.00 per share(500%)Dividend & A.G.M. 
08-May-10 20-May-10   A.G.M. & Rs.10.00 per share(500%)Dividend 
05-May-09 18-May-09   750% Dividend & A.G.M. 
16-Apr-08 28-Apr-08   A.G.M. & 750% Dividend 
27-Apr-07 30-Apr-07   A.G.M. & 600% Dividend (Cancelled) 
14-Apr-06 28-Apr-06   200% Dividend & A.G.M. 
22-Mar-05 06-Apr-05   500% Dividend & A.G.M. 
20-Apr-04 05-May-04   Shares 39% Dividend & A.G.M. 
22-Apr-03 28-Apr-03   Shares 37% Dividend 
Page 1 of 1
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.